Synthetic Biologics

+$0.0037 (+1.95%) Today
-$0.0037 (-1.91%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SYN and other ETFs, options, and stocks.

About SYN

Synthetic Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-020 and SYN-004.

CEO
Steven A. Shallcross
Employees
16
Headquarters
Rockville, Maryland
Founded
2001

SYN Key Statistics

Market cap
30.72M
Price-Earnings ratio
—
Dividend yield
—
Average volume
658.20K
High today
$0.1948
Low today
$0.1901
Open price
$0.1911
Volume
451.86K
52 Week high
$0.6397
52 Week low
$0.18

SYN Earnings

-$0.17
-$0.11
-$0.06
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure